Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company based in Tarrytown, New York, United States, that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.

Regeneron has developed a monoclonal antibody cocktail, which is currently being investigated for the treatment of multiple sclerosis (MS). The cocktail is composed of three separate monoclonal antibodies, which work together to reduce inflammation and damage caused by MS.

The cocktail has been shown to be effective in reducing inflammation and damage in …